Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 USD | -3.95% | -0.29% | -47.84% |
May. 08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
May. 08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.84% | 652M | |
+31.87% | 694B | |
+29.38% | 593B | |
-1.62% | 371B | |
+19.73% | 331B | |
+6.60% | 290B | |
+14.17% | 239B | |
-2.94% | 209B | |
+10.04% | 209B | |
+8.04% | 169B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- Transcript : EyePoint Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 04, 2022